Newsroom | 8801 results

Sorted by: Latest

Environmental, Social and Governance (ESG)
-

“International Consumer's Symposium in Tokushima 2026” to be livestreamed on October 17

TOKUSHIMA, Japan--(BUSINESS WIRE)--The Tokushima Prefectural Government will hold the “International Consumer's Symposium in Tokushima 2026” on October 17. This symposium will gather consumer policy experts and the next generation of young people from Japan and abroad in Tokushima to discuss policies for achieving ethical consumption (including food loss reduction) and SDGs (Sustainable Development Goals). Worsening climate change, concerns about energy supply, accelerating digitalization... Ho...
-

Light & Wonder Releases 2025 Global Corporate Social Responsibility Report

LAS VEGAS--(BUSINESS WIRE)--Light & Wonder, Inc. (ASX: LNW) (together with its subsidiaries “Light & Wonder,” “L&W” or the “Company”) today released its 2025 Global Corporate Social Responsibility (“CSR”) Report. The report marks a shift in the Game Changers program from building foundations to driving measurable outcomes, supported by two years of greenhouse gas emissions data, an improving approach to data management and dedicated committees for each of its six pillars: People, Co...
-

ADS Foundation and Brightstorm Introduce a Smarter Way to Manage Stormwater at WEFTEC 2026

NEW ORLEANS--(BUSINESS WIRE)--The ADS Foundation and The Nature Conservancy’s Brightstorm program are joining efforts at WEFTEC 2026 – the largest water conference in North America, taking place September 26-30 in New Orleans. They will showcase Smart Watershed Network Management (SWNM) and how smart stormwater systems can upgrade legacy infrastructure to better manage stormwater, protect water quality, reduce flooding, and support the nature on which all life depends.The collaboration reflects...
-

Voya supports SEC effort to modernize delivery of investor information

NEW YORK--(BUSINESS WIRE)--Voya Financial, Inc. (NYSE: VOYA) announced that it has submitted a comment letter to the U.S. Securities and Exchange Commission (SEC) supporting the agency’s proposal to modernize how required investor disclosures and other information may be delivered electronically. Voya applauded the SEC’s effort to update a framework that currently defaults to paper delivery, recognizing that many Americans increasingly access and manage important information online. The company...
-

Samenvatting: SPORVIGILANCE richt zich op veiligere geneesmiddelen en besparing van miljarden euro's voor wereldwijde farmaceuticabedrijven die EU IDMP-boetes worden opgelegd

LONDEN--(BUSINESS WIRE)--Het Britse regtech-bedrijf SPORVIGILANCE richt zich op een van de grootste nalevingsuitdagingen van de farmaceutische sector met een platform dat een snellere route biedt naar IDMP- en SPOR-paraatheid, naleving en beheer. Nu de EMA (European Medicines Agency) gestructureerde gegevens over geneesmiddelen vooropstelt, komen bedrijven onder druk om regulatorische gegevens nauwkeurig, gestandaardiseerd en conform met EMA-vereisten te houden. SPORVIGILANCE vervangt gefragmen...
-

SPORVIGILANCE strebt sicherere Arzneimittel und Einsparungen in Milliardenhöhe für die globale Pharmaindustrie an, die mit IDMP-Bußgeldern der EU konfrontiert ist

LONDON--(BUSINESS WIRE)--Das britische RegTech-Unternehmen SPORVIGILANCE nimmt eine der größten Compliance-Herausforderungen der globalen Pharmaindustrie ins Visier – mit einer Plattform, die einen schnelleren Weg zur IDMP- und SPOR-Bereitschaft, Compliance und Governance bietet. Da die Europäische Arzneimittelagentur (EMA) strukturierte Arzneimitteldaten vorantreibt, stehen Unternehmen unter dem Druck, regulatorische Daten korrekt, standardisiert und im Einklang mit den EMA-Anforderungen zu ha...
-

SPORVIGILANCE vise à rendre les médicaments plus sûrs et à faire des économies se chiffrant en milliards d'euros pour l'industrie pharmaceutique mondiale, confrontée aux amendes de l'UE liées à la norme IDMP

LONDRES--(BUSINESS WIRE)--L'entreprise britannique de technologie réglementaire SPORVIGILANCE s'attaque à l'un des principaux défis de conformité de l'industrie pharmaceutique mondiale grâce à une plateforme permettant d'accélérer la préparation, la conformité et la gouvernance de la norme IDMP et des données SPOR. Alors que l'Agence européenne des médicaments fait progresser la structuration des données sur les médicaments, les entreprises sont confrontées à la nécessité de maintenir l'exactit...
-

SPORVIGILANCE Targets Safer Medicines and Billion-Euro Savings for Global Pharma Facing EU IDMP Fines

LONDON--(BUSINESS WIRE)--British regulatory technology company SPORVIGILANCE is targeting one of global pharma’s major compliance challenges with a platform offering a faster route to IDMP and SPOR readiness, compliance and governance. As the European Medicines Agency advances structured medicinal product data, companies face pressure to keep regulatory data accurate, standardised and aligned with EMA requirements. SPORVIGILANCE replaces fragmented manual assessment with a regulatory intelligen...
-

Riassunto: SPORVIGILANCE punta a farmaci più sicuri e a risparmi pari a un miliardo di euro per l'industria farmaceutica a livello globale soggetta alle penalità dell'UE in materia di IDMP

LONDRA--(BUSINESS WIRE)--La società britannica specializzata in tecnologia normativa SPORVIGILANCE punta a una delle maggiori sfide di conformità per il settore farmaceutico globale con una piattaforma che offre un percorso più rapido a preparazione, conformità e governance relative all'IDMP e allo SPOR. Man mano che l'Agenzia europea per i medicinali (EMA) porta avanti dati strutturati di prodotti medicinali, le aziende sono soggette a pressioni per mantenere i dati accurati, standardizzati e...
-

Resumen: SPORVIGILANCE apunta a lograr medicamentos más seguros y un ahorro de mil millones de euros para la industria farmacéutica mundial, en el marco de las multas de la UE por las normas IDMP

LONDRES--(BUSINESS WIRE)--La empresa británica de tecnología regulatoria SPORVIGILANCE apunta a resolver uno de los principales desafíos de cumplimiento normativo de la industria farmacéutica mundial con una plataforma que ofrece una vía más rápida para facilitar la preparación, el cumplimiento y la gobernanza en materia de normas IDMP y SPOR. La Agencia Europea de Medicamentos (EMA) promueve la disponibilidad de los datos estructurados sobre los medicamentos y en ese sentido, las empresas se v...